| 000 | 01393 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513231233.0 | ||
| 264 | 0 | _c20001207 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a0741-238X | ||
| 024 | 7 |
_a10.1007/BF02850295 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMundo-Gallardo, F | |
| 245 | 0 | 0 |
_aLatin American open-label study with rabeprazole in patients with functional dyspepsia. Mexican Rabeprazole Investigators Group. _h[electronic resource] |
| 260 |
_bAdvances in therapy _c |
||
| 300 |
_a190-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _a2-Pyridinylmethylsulfinylbenzimidazoles |
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzimidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aDyspepsia _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOmeprazole _xanalogs & derivatives |
| 650 | 0 | 4 |
_aProton-Translocating ATPases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRabeprazole |
| 700 | 1 | _aDe Mezerville-Cantillo, L | |
| 700 | 1 | _aBurgos-Quiroz, H | |
| 700 | 1 | _aIzquierdo, E | |
| 700 | 1 | _aChang-Mayorga, J | |
| 700 | 1 | _aAzteguieta, L | |
| 700 | 1 | _aPassarrelli-Sandhoff, L F | |
| 773 | 0 |
_tAdvances in therapy _gvol. 17 _gno. 4 _gp. 190-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02850295 _zAvailable from publisher's website |
| 999 |
_c11123266 _d11123266 |
||